113 related articles for article (PubMed ID: 3303431)
1. [Influence of fluidifying agents on the penetration of antibiotics in respiratory secretions].
Berthelot G; Pierre J; Bergogne-Berezin E
Therapie; 1987; 42(2):193-6. PubMed ID: 3303431
[No Abstract] [Full Text] [Related]
2. Influence of a fluidifying agent (bromhexine) on the penetration of antibiotics into respiratory secretions.
Bergogne-Bérézin E; Berthelot G; Kafé HP; Dournovo P
Int J Clin Pharmacol Res; 1985; 5(5):341-4. PubMed ID: 4066084
[TBL] [Abstract][Full Text] [Related]
3. Use of ambroxol and bromhexine as mucolytics for enhanced diffusion of furaltadone into tracheobronchial secretions in broilers.
Sumano H; Gracia I; Capistrán A; Meade G; Rivero A; Ruiz-Ramírez L
Br Poult Sci; 1995 Jul; 36(3):503-7. PubMed ID: 7583380
[TBL] [Abstract][Full Text] [Related]
4. Activity of bromhexine and ambroxol, semi-synthetic derivatives of vasicine from the Indian shrub Adhatoda vasica, against Mycobacterium tuberculosis in vitro.
Grange JM; Snell NJ
J Ethnopharmacol; 1996 Jan; 50(1):49-53. PubMed ID: 8778507
[TBL] [Abstract][Full Text] [Related]
5. [Round table. Relevant controls and usefulness of treatments modifying bronchial secretions (author's transl)].
Bull Physiopathol Respir (Nancy); 1973; 9(2):417-71. PubMed ID: 4778961
[No Abstract] [Full Text] [Related]
6. Influence of ambroxol on the bronchopulmonary level of antibiotics.
Wiemeyer JC
Arzneimittelforschung; 1981; 31(6):974-6. PubMed ID: 7196243
[TBL] [Abstract][Full Text] [Related]
7. [Drug therapy of bronchosecretolytic disorders].
Schmidt OP
Med Klin; 1977 Feb; 72(5):145-60. PubMed ID: 321928
[No Abstract] [Full Text] [Related]
8. Pharmacokinetic study of beta-lactam antibiotics in bronchial secretions.
Bergogne-Berezin E; Morel C; Benard Y; Berthelot G; Kafe H
Scand J Infect Dis Suppl; 1978; (14):267-72. PubMed ID: 279981
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of lung levels of antibiotics by ambroxol and bromhexine.
Deretic V; Timmins GS
Expert Opin Drug Metab Toxicol; 2019 Mar; 15(3):213-218. PubMed ID: 30721101
[TBL] [Abstract][Full Text] [Related]
10. [Effect of a secretolytic agent (bromhexine) on the penetration of erythromycin into bronchial secretions].
Bergogne-Berezin E; Pierre J; Dournovo P
Fortschr Med; 1982 Jun; 100(24):1169-71. PubMed ID: 7049878
[TBL] [Abstract][Full Text] [Related]
11. [Modifications of the immunoglobulins in bronchial secretions induced by treatment with bromexin and oxytetracycline].
Olivieri D; Bocchino M; Caputi M
Arch Monaldi; 1970; 25(6):537-44. PubMed ID: 4105892
[No Abstract] [Full Text] [Related]
12. A simple method for the determination of the thread-forming property of tracheobronchial secretions.
Iravani J; Melville GN
Respiration; 1976; 33(4):289-93. PubMed ID: 7008
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacokinetic study of antibiotics in human respiratory tract (author's transl)].
Bergogne-Berezin E; Morel C; Even P; Benard Y; Kafe H; Berthelot G; Pierre J; Lambert-Zechovsky N
Nouv Presse Med; 1978 Sep; 7(32):2831-6. PubMed ID: 714663
[TBL] [Abstract][Full Text] [Related]
14. [Serum and bronchial concentrations of amoxicillin administered with a bronchial fluidizer].
Concia E; Dos Santos C; Marone P; Sardi C; Cremaschi P
Boll Ist Sieroter Milan; 1982 Mar; 61(1):64-70. PubMed ID: 7126331
[TBL] [Abstract][Full Text] [Related]
15. [Bronchial secretions: biochemical study. Physiopathological aspects].
Lafitte JJ; Laine A; Hayem A; Petitprez D; Roussel P; Degand P
Eur J Respir Dis Suppl; 1980; 111():25-8. PubMed ID: 6938406
[TBL] [Abstract][Full Text] [Related]
16. [Experimental study of the possible influence of a fluidifying agent (bromhexine) on the penetration of erythromycine into bronchial secretions (author's transl)].
Bergogne-Berezin E; Pierre J; Dournovo P
Therapie; 1979; 34(6):705-11. PubMed ID: 547444
[No Abstract] [Full Text] [Related]
17. Differential modulation of IgE-dependent activation of human basophils by ambroxol and related secretolytic analogues.
Gibbs BF
Int J Immunopathol Pharmacol; 2009; 22(4):919-27. PubMed ID: 20074455
[TBL] [Abstract][Full Text] [Related]
18. Ambroxol decreases bronchial hyperreactivity.
Melillo G; Cocco G
Eur J Respir Dis; 1986 Nov; 69(5):316-20. PubMed ID: 3539631
[TBL] [Abstract][Full Text] [Related]
19. [Controlled clinical study on the activity of a new mucoregulating drug in obstructive bronchial pathology with a marked hypersecretory feature. The pediatric experience].
Romano C; Gargani GF; Minicucci L; Nantron M
Minerva Pediatr; 1984 Feb; 36(3):127-38. PubMed ID: 6374414
[No Abstract] [Full Text] [Related]
20. [Clinical results in the treatment of chronic obstructive bronchitis with ambroxol in comparison with bromhexine (author's transl)].
Wiessmann KJ; Niemeyer K
Arzneimittelforschung; 1978; 28(5a):918-21. PubMed ID: 373777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
